Literature DB >> 1494702

[Lateral approach of the knee with tibial tubercle osteotomy for prosthetic surgery].

P Mertl1, O Jarde, D Blejwas, P Vives.   

Abstract

The authors describe a lateral approach to the knee associated with a tibial tubercle osteotomy and a plasty using the fat pad to provide a complete closure of the wound. This lateral approach has been performed successfully in 98 cases, with only 3 skin necrosis. It offers a large exposure of the joint, facilitates placement of tibial component trial fit, and allows the self centering of the quadriceps patellar-tendon mechanism at the end of the intervention. The lateral approach disputable in case of genu varum is recommended in all cases of genu valgum or important deformities.

Entities:  

Mesh:

Year:  1992        PMID: 1494702

Source DB:  PubMed          Journal:  Rev Chir Orthop Reparatrice Appar Mot        ISSN: 0035-1040


  4 in total

1.  Total knee replacement in the fixed valgus deformity using a lateral approach: role of the automatic iliotibial band release for a successful balancing.

Authors:  P Boyer; D Boublil; B Magrino; P Massin; D Huten
Journal:  Int Orthop       Date:  2008-12-09       Impact factor: 3.075

2.  Anterolateral approach using tibial tubercle osteotomy for total knee arthroplasty: can we predict failure?

Authors:  Marc Wishart; Markus P Arnold; Rolf W Huegli; Felix Amsler; Niklaus F Friederich; Michael T Hirschmann
Journal:  Int Orthop       Date:  2012-11-06       Impact factor: 3.075

3.  [Lateral approach to the knee combined with an osteotomy of the tibial tuberosity. Its use for total knee replacement].

Authors:  M P Arnold; N F Friederich; H Widmer; W Müller
Journal:  Oper Orthop Traumatol       Date:  1999-09       Impact factor: 1.154

4.  Does low-constraint mobile bearing knee prosthesis give satisfactory results for severe coronal deformities? A five to twelve year follow up study.

Authors:  Jaroslaw Czekaj; Camdon Fary; Thierry Gaillard; Sebastien Lustig
Journal:  Int Orthop       Date:  2017-04-11       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.